Gene · 56034
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis. | Front Mol Biosci | 2023 | 37152902 | PubTator, text mining | PubMed |
| The effects of mechanical force on fibroblast behavior in cutaneous injury. | Front Surg | 2023 | 37143767 | PubTator, text mining | PubMed |
| Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors. | Pharmacol Res | 2023 | 37127213 | PubTator, text mining | PubMed |
| Novel Biomarker Prediction for Lung Cancer Using Random Forest Classifiers. | Cancer Inform | 2023 | 37113644 | PubTator, text mining | PubMed |
| New Biosensor for Determination of Neuropilin-1 with Detection by Surface Plasmon Resonance Imaging. | Sensors (Basel) | 2023 | 37112459 | PubTator, text mining | PubMed |
| Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation. | Development | 2023 | 37102682 | PubTator, text mining | PubMed |
| DEGGs: an R package with shiny app for the identification of differentially expressed gene-gene interactions in high-throughput sequencing data. | Bioinformatics | 2023 | 37084249 | PubTator, text mining | PubMed |
| The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration. | Int J Mol Sci | 2023 | 37047617 | PubTator, text mining | PubMed |
| Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives. | Cancers (Basel) | 2023 | 37046734 | PubTator, text mining | PubMed |
| Fibroblasts as Turned Agents in Cancer Progression. | Cancers (Basel) | 2023 | 37046676 | PubTator, text mining | PubMed |
| Expansion and collapse of VEGF diversity in major clades of the animal kingdom. | Angiogenesis | 2023 | 37017884 | PubTator, text mining | PubMed |
| N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms. | Front Immunol | 2023 | 36999016 | PubTator, text mining | PubMed |
| Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease. | Front Cardiovasc Med | 2023 | 36998978 | PubTator, text mining | PubMed |
| Vascular Progenitor Cells: From Cancer to Tissue Repair. | J Clin Med | 2023 | 36983398 | PubTator, text mining | PubMed |
| HSPA5 Promotes the Proliferation, Metastasis and Regulates Ferroptosis of Bladder Cancer. | Int J Mol Sci | 2023 | 36982218 | PubTator, text mining | PubMed |
| Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells. | Biomedicines | 2023 | 36979654 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated heterogeneous communication between cancer and the lymphatic system facilitates lymphatic metastasis. | Cancer Biol Med | 2023 | 36971125 | PubTator, text mining | PubMed |
| Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2. | J Transl Med | 2023 | 36966336 | PubTator, text mining | PubMed |
| Identification of the regulatory mechanism of ACE2 in COVID-19-induced kidney damage with systems genetics approach. | J Mol Med (Berl) | 2023 | 36951969 | PubTator, text mining | PubMed |
| Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19. | Exp Mol Med | 2023 | 36941461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56034/papers?page=11